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Abstract
Ticks are distributed worldwide and significantly impact human and animal health. Due to severe
problems associated with the continuous use of acaricides on animals, integrated tick management is
recommended. Increasing public health concern over the tick-borne diseases demands the strategic
control of ticks on animals that transmit diseases to human beings. Immunological control of tick
vector of Kyasanur Forest Disease (KFD) on cattle and other wild reservoir hosts is one of the
possible alternative strategy for reducing the transmission of KFD to man. Chemical-vaccine syner-
gies have been demonstrated and a combination of chemical and vaccine for tick and tick-borne
disease control has been identified as a sustainable option. Studies have suggested the possibility of
vaccine strategies directed towards both tick control and transmission of pathogens. Besides tick
vaccine, use of endosymbionts, which are essential for the survival of arthropod hosts, for the control
of tick vectors will be one of the targeted areas of research in near future. India with huge natural
resources of herbs and other medicinal plants, the possibilities of developing herbal acaricides is
discussed. The future of research directed towards target identification is exciting because of new
and emerging technologies for gene discovery and vaccine formulation.
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Introduction
On global basis, ticks transmit a number of pathogen-
ic organisms like protozoans, rickettsiae, spirochaetes
and viruses, than any other arthropod vector group,
and are among the most important vectors of diseas-
es affecting livestock, humans and companion ani-
mals1. Besides acting as vector, the direct effects of
ticks have great economic importance since tick bite
marks diminishes up to 20–30% of the value of skins
and hides2. De Castro3  estimated the global costs of
ticks and tick-borne diseases (TTBDs) in cattle be-
tween US$ 13.9 and US$ 18.7 billion annually. In
India alone the cost of TTBDs in animals has been es-
timated in the tune of US$ 498.7 million (more than
2000 crores) per annum4.  Over the past two decades,
the incidence of tick-borne diseases (TBDs) increased
and pose a major public health problem in Europe5.
The recent report of increasing number of KFD in
Karnataka state of India, despite routine vaccination
indicates the insufficient efficacy of the vaccine pro-
tocol6 and necessitates the need for strategic control
of the tick vector. Although research efforts were
directed towards the development of vaccines against
the tick-borne pathogens, the results obtained till date
are not satisfactory (Table 1). Therefore, at present,
TTBDs control is mainly effected by widespread use
of acaricides like organophosphates, carbamates,
pyrethroids, BHC/cyclodines, amidines, macrocyclic
lactones and benzoylphenylureas leading to various
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problems such as resistance, residues, environmental
pollution and high cost. These factors reinforce the
need for alternative approaches to control tick infes-
tations.
The integrated pest/vector management (IPM) has
been identified as the future sustainable option of tick
control10,11. As an important component of IPM, cat-
tle tick vaccine in the form of TickGARDTM  (Escher-
ichia coli expressed BM86 vaccine) and TickGARD
plusTM (E. coli expressed BM86+BM91) and Ga-
vacTM (Pichia pastoris expressed Bm86 vaccine),
have been developed and commercialised12,13. The
vaccine was based on a concealed glycoprotein (89
kDa) isolated from the mid gut of Boophilus mi-
croplus.  Besides the concealed antigen approach,
exposed antigens have been targeted to develop vac-
cine against tick species. For example, Mulenga et
al14 characterised a 29 kDa salivary gland-associat-
ed protein from Haemaphysalis longicornis and vac-
cination with recombinant protein produced in E. coli
led to a significant reduction in adult female engorge-
ment weight and 40% and 56% mortality of larvae
and nymphs post-engorgement, respectively.  Recent-
ly, a 15 kDa protein from R. appendiculatus, 64P, was
identified as a putative cement protein involved in
attachment and feeding of ticks. Vaccination of guin-
ea pigs with recombinant versions of the 64P protein
(64 TRPs) resulted in reduction of the nymphal and
adult infestation rates by 48 and 70%, respectively15.
An important impact of controlling tick infestations
is the reduction of medically and economically im-
portant tick-borne pathogens. For example, in exten-
sive field trials immunisation of cattle with Bm86
Table 1.  Important tick-borne diseases of human and livestock in India
Tick-borne diseases (TBD) Pathogen/Parasite Tick vector Host Vaccine status
 against TBD
Kyasanur Forest Disease KFD virus Haemophysalis Man Chick embryo
(KFD) spinigera tissue culture vaccinea
Crimean Congo Hemorrhagic CCHF virus Hyalomma spp? Man Nil
Fever (CCHF)7
Indian Tick Typhus (ITT)8,9 Rickettsia conorii Rhipicephalus Man Nil
sanguineus?
Bovine Tropical Theileriosis Theileria annulata Hyalomma anatolicum Cattle Attenuated
anatolicum macroschizont vaccineb
Babesiosis Babesia  bigemina Boophilus microplus Cattle, Buffalo Nil
B. motasi Haemaphysalis sp Goat Nil
B. canis R. sanguineus Dog Nil
B. ovis Rhipicephalus sp Sheep Nil
B. equi Hyalomma sp Horse Nil
Anaplasmosis Anaplasma B. microplus Cattle, Bufallo, Nil
marginale Sheep
Ehrlichiosis Ehrlichia bovis, Hyalomma sp Cattle Nil
E. canis R. sanguineus Dog Nil
aNot fully effective in field situation6; bEffective but not in large-scale use; ? Tick species not yet confirmed.GHOSH et al :  TICK CONTROL STRATEGIES: A REVIEW 81
vaccines resulted in a reduction in the incidence of
babesiosis as well as reduced tick infestations13,16.
Similarly, transmission of tick-borne encephalitis
(TBE) viruses have been prevented by immunisation
of mice with recombinant tick cement protein, 64P15.
Recombinant tick vaccines, therefore, could be target-
ed for control of TTBDs. The development of exist-
ing tick vaccines and their effect on the targeted vec-
tors and pathogens has been reviewed17. The present
review is focused on upcoming and future tick con-
trol strategies keeping in view of the technological de-
velopment in the post-genomic era.
Upcoming tick control strategies
(A) Tick vaccine
(i) Target identification
Expression library immunisation and RNAi: Ex-
pression library immunisation (ELI) in combination
with sequence analysis of expressed sequence tags
(ESTs), provides an efficient global approach for
identification of vaccine antigens that is based on
rapid screening of the expressed genes. This method
allows for antigen identification without introducing
prior criteria to direct the selection of candidate genes
and thus may result in the discovery of novel and
unexpected antigens18,19.
Although the application of ELI in combination with
EST analysis represented an improved method for iden-
tification of tick protective antigens, experimental im-
munisation and challenge tick infestation of a large
number of laboratory animals are laborious, expensive
and difficult to standardise. While the laboratory animal
model of tick infestations is restricted to selected tick
species, many other tick species (especially Boophilus
spp) would require larger animal hosts for tick feeding,
such as sheep and cattle, and would thus contribute to
the complexity of the screening experiments.
The genome and EST work has generated a huge pool
of coding sequences, but the functions of many of
them are still unknown or poorly understood. RNA
interference (RNAi) is becoming an increasingly
powerful post-transcriptional gene silencing tech-
nique that is providing insight into gene function20,21.
This reverse vaccinology approach reduces the use of
animal challenge experimentation and allows rapid
screening of protective tick antigens.
The RNAi process involves an ATP-dependent pro-
duction of small ≈21–25 nucleotide, short interfering
RNA molecules (siRNAs) from double stranded RNA
(dsRNA) by dicer ribonuclease and is believed to be
responsible for targeting and destroying specific
mRNAs facilitated by the formation of the RNA-in-
duced silencing complex (RISC). The RISC RNA
molecules complementary to the mRNAs seem to
work as a guide,  recruiting a ribonuclease  that  con-
sequently  cleaves  only  specific mRNAs22–24.
Aljamali et al25 hypothesised that ticks have the ma-
chinery that processes the dsRNA into siRNAs, which
target specific mRNAs as this homeostatic silencing
pathway seems to be conserved in several other eu-
karyotes21.  They reported the application of RNAi
in the study of histamine binding protein (HBP) of
female tick, Amblyomma americanum. The HBP
dsRNA was synthesised from A. americanum HBP
dsDNA by RNA polymerases (in vitro transcription).
Unfed female A. americanum ticks were microinject-
ed with 1010 dsRNA molecules in injection buffer.
Reduction in daily weight gain and extended feeding
time were observed in the dsRNA injected ticks.
Moreover, HBP transcript levels were low in exper-
imental group ticks than the control group. Both the
differences in feeding and the pronounced decrease
in the HBP mRNA indicate the ability of dsRNA to
spread from the injection site to the salivary glands.
Bioinformatics: In recent years due to the explosion
in biological information, there has been a move from
the classical linear approach of drug/vaccine target
identification to non-linear and high throughput ap-82 J  VECT  BORNE  DIS  44, JUNE 2007
proach. It appears that the ability to generate vast
quantities of data has surpassed the ability to use this
data meaningfully. The genomics information can be
effectively used for the identification and validation
of vaccine targets. The genome project for Ixodes
scapularis is underway and in near future the full
genome sequence of other veterinary and medically
important ticks will be available. The accumulation
of these information into databases will help us to
identify potential vaccine and acaricide targets and it
can save much time and expenses on target identifi-
cation by conventional methods.
The types of information need for the identification
of potential vaccine targets include nucleotide and
protein sequence, homologues, mapping information,
domains, motifs, structure and function prediction,
pathway information, disease associations, variants,
protein expression data and species, taxonomic dis-
tributions among others. The protective homologues
can be identified in a range of tick species and exploit-
ed for the purpose of recombinant vaccines. Compar-
ative genomics help us to find protein families that are
widely and taxonomically dispersed and those are
unique to a particular tick species. This will help us
to identify vaccine targets for a broad spectrum anti-
tick vaccine. Due to the advances in the computation-
al biology, finding an attractive target is no longer a
problem but finding the targets that are most likely to
succeed has become the challenge.
(ii) Vaccine development
DNA vaccination against ticks: DNA vaccine devel-
opment is still in its infancy for ticks of veterinary and
medical importance. Since the BM86 antigen present
in the commercial anti-Boophilus vaccine, located in
the mid-gut of the tick, doesn’t normally enter into
contact with the bovine immune system, no booster
to the primary vaccination is provided during subse-
quent natural infestation. Though the efficacy of the
vaccination depends on the magnitude and persis-
tence of the antibody, repeated boosting is essential
for the vaccine effectiveness. In DNA vaccination, the
injected plasmid DNA molecules believed to enter
nucleus actively and remain in side the nucleus as
episomal DNA lifelong, thus generating the protec-
tive antigens continuously as long as the cell lives7.
The continuous synthesis, processing and presenta-
tion of antigens to T-cells in vivo in DNA vaccinated
animals could avoid the problem of repeated boost-
ing to maintain high antibody titer. Moreover, as DNA
vaccine consists only of plasmid DNA and no con-
taminating proteins, multiple or repeated vaccination
would seem possible without generating immune
response to vector DNA26.
De Rose et al27 attempted the DNA vaccination of
Merino crossbred sheep against B. microplus using
Bm86 full length gene. Though the antibody titer of
the immunised animals was low, a marginal decrease
(not significant) in mean engorgement weight of fe-
male ticks was observed. Apart from that, the DNA
vaccination had primed for a significant anamnestic
response to protein antigen. In addition, covaccina-
tion with Bm86 and GM-CSF plasmids gave statis-
tically significant reduction in the fertility of ticks.
But in positive control, vaccination of sheep with
TickGARDplus induced strong protection (25 times
more effective than DNA vaccination) as measured
by all parasitological parameters.
Since humoral immune response plays a major role
in tick immunity, a DNA vaccine is to be designed
to polarise the host immune response towards Th2
response. The levels of specific IgG1 which appear
to be regulated by Th2 cells in cattle vaccinated
with mid-gut antigens of B. microplus were found
to correlate with protection. Placing appropriate
secretory signal sequence downstream of the tar-
get gene would allow the target antigen to be se-
creted out to the extracellular compartment and
elicit better humoral immune response. Moreover,
coinfection with the other immunomodulatory
genes like IL4 and IL10 would favour the selection
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Future strategies
(A) Tick vaccine
(i) Target identification
Endosymbiotic approach: Endosymbionts of ticks
are almost unexplored and appear to be a potential tar-
get for the control of ticks. This is because very few
studies that involved the identification and character-
isation of the endosymbiotic organisms of ticks28,29.
They are commonly found in the arthropods that al-
ways depend on single source of diet that is deficient
of some nutrients. As in the case of ticks they always
depend on host blood as only food source that may not
provide all the essential nutrients to the growth and
development of ticks. So, ticks must have many pri-
mary endosymbionts that are not yet characterised.
The endosymbionts are heritable and transmitted to
the progenies through vertically or maternally. This
association is obligate or beneficial to the arthropod
host.
Since endosymbiotic organisms are essential for the
survival of the arthropod host, elimination of the
organism would be deleterious for their survival.
Understanding the genetics and physiology of endo-
symbionts is essential in devising strategies which are
based on interference with their endosymbionts for
the control of these vectors.
Tick control in future can be attempted by exploiting
endosymbionts, by chemotherapeutic, immunologi-
cal and microbiological approaches. Before consid-
ering these approaches some basic studies on endo-
symbionts of different tick species like identification,
microbiological and molecular characterisation and
in vitro cultivation of the organisms should be initi-
ated.
Chemotherapeutic approach:  Recent field reports of
ivermectin resistance amongst ticks30 necessitates the
search for another systemic antibiotic for the control
of ticks. Targeting the endosymbionts of tick species
through antibiotics would be easy to apply against the
blood feeding parasites like ticks, as antibiotics or
antibacterial can be systemically administered to the
animals so as to reach the endosymbionts inside the
tick, especially in the gut region. As observed in most
of the arthropod species, the endosymbionts of ticks
would be essential for their growth and development
and by disturbing the endosymbionts of ticks, the life
of ticks could be jeopardised.  The observations on the
effect of antibiotics on the endosymbionts of tsetse fly
and a filarial nematode Litomosoides sigmodontis
give an optimistic look towards this approach. Steril-
ity was observed in healthy tsetse flies  fed  with
tetracycline  (2500 μg/ml)  due to  damage  to the
mycetome  bacterial  endosymbionts31.   Available an-
tibacterial and antibiotics can be screened against the
endosymbionts of ticks and subsequently can be test-
ed systemically against challenge infestation. Of
course, the non-availability of any in vitro cultivation
methods for the endosymbionts of ticks can only defer
but can’t stop the testing of the above hypothesis in
future.
Immunological approach:  Animals can be immu-
nised with the whole killed endosymbionts or puri-
fied antigens or recombinant antigens of the endo-
symbionts. The concealed antigens or the mid gut an-
tigens of the blood feeding arthropods like ticks, glos-
sina, mosquitoes are the potential vaccine targets
being exploited by the researchers for the control of
vectors7. Instead of targeting the host (vector) anti-
gens, the endosymbionts could be targeted to disturb
the symbiotic relationship between the vector and the
symbiont. If the animals are immunised with antigens
of endosymbiont, antibodies will be produced against
it. Following ingestion of the blood from immunised
animals, these antibodies together with other compo-
nents of the immune system such as complement, will
destroy the symbionts, leading either to death or to
disruption of normal gut physiology of the tick and
reduce growth and egg-laying ability. For the produc-
tion of whole killed bacterial endosymbionts or the84 J  VECT  BORNE  DIS  44, JUNE 2007
native purified protective antigens of endosymbionts
in vitro culture of the organisms is essential. But, the
in vitro culture of the endosymbionts especially the
primary endosymbionts is very difficult with the
common laboratory media. Thus, a specific media for
culturing these symbionts of ticks is to be developed
to proceed further.
Tick genome project: Tick genomic study is expect-
ed to boost the development of novel methods for tick
control and blocking parasite/pathogen transmission.
The Ixodes scapularis is the first tick to be taken up
for genome sequencing. This genome data will pro-
vide information about many aspects of tick biology
and will enable the identification of unique tick genes
and physiological process that could be exploited for
TTBDs control. Identification of novel vaccine tar-
gets through genome analysis of I. scapularis is ex-
pected to widen the scope of tick research in India.
The homologues genes of economically important In-
dian tick species, viz. B. microplus, H. a. anatolicum,
Haemaphysalis spinigera can be screened for their
candidature as vaccine target.
(ii) Vaccine development
Cocktail vaccines against tick and tick borne
diseases: Although reduction in disease transmission
potential of ticks is achieved by vaccination against
ticks13–15,32, a cocktail vaccine against both tick and
pathogen/parasite is expected to give an even higher
level of protection against TBDs. A possibility for the
development of such a combination vaccine against
T. parva–R. appendiculatus and T. annulata–H. a.
anatolicum systems may exist. A novel subunit vac-
cine against T. parva, has been recently evaluated for
its vaccine potential in cattle33,34.  Additionally, the
homologue of Bm86 has been discovered in
R. appendiculatus (Ra86). The recombinant Tams 1
antigen of T. annulata (Parbhani strain) and the Bm86
homologue antigen of H. a. anatolicum (Izatnagar
isolate), rHAA86, were produced in E.coli and Pichia
pastoris, respectively in the Division of Parasitology,
Indian Veterinary Research Institute, Izatnagar, In-
dia35. A cocktail vaccine consisting of antigens Tams
1 and rHAA86 is expected to protect Indian cattle
population against H. a. anatolicum and T. annulata.
Broad spectrum anti-tick vaccine: Multiple tick spe-
cies infestation on animals is impedance to the use of
tick vaccines with a narrow spectrum, having anti-
gens of a single tick species. The recombinant BM86
included in commercial vaccine formulations Tick-
GARD (Hoechst Animal Health, Australia) and Ga-
vac (Heber Biotec S.A., Havana, Cuba) confers par-
tial protection against phylogenetically related Hy-
alomma and Rhipicephalus tick genera . However,
immunisation with BM86 failed to protect against the
more phylogenetically distant Amblyomma spp36.
Therefore, there remains a need to identify broad
range vaccine candidates against tick infestations
across phylogenetically distant species.
Tick genes encoding for protective antigens have
been discovered that are expressed across tick species
and in some circumstances across genera, thus mak-
ing the use of these cross reactive antigens in broad
range anti-tick vaccine formulations perhaps possi-
ble. These genes were cloned and associated polypep-
tides of I. scapularis were designated as 4D8 (also
identified as subolesin), 4F8 and 4E618,19,37,38. The
sequence of 4D8 was shown to be conserved among
different tick genera and the activity of subolesin
protective antigen was demonstrated to extend to
other tick species, including non-Ixodes tick spe-
cies39. The 4D8 molecule is expected to present in im-
portant tick species of India.
Recombinant forms of the secreted R. appendicula-
tus tick cement antigens, 64 TRP’s may act as a ‘dual
action’ anti-tick vaccine in that they target both ‘ex-
posed’ and ‘concealed’ antigens37,38. Ticks feeding on
64TRP’s immunised guinea pigs induce a cutaneous
inflammatory response and increased antibody titer,
which is detrimental to engorged ticks. This dual
action, acting at the feeding site and in the midgut,GHOSH et al :  TICK CONTROL STRATEGIES: A REVIEW 85
confers a self-sustaining strategy for tick control
boosted by natural infestations. Immunoblotting stud-
ies using tick tissue extracts with antisera to different
64 TRP constructs reveal antigenic cross-reactivity
with R. sanguineus, I. ricinus, A. variegatum and B.
microplus.  In vaccine trials using guinea pigs, rab-
bits, and hamsters, the 64 TRP constructs provided
cross-protection against R. sanguineus and I. ricinus,
apparently by targeting antigens in the cement cone,
midgut and salivary glands of adults and nymphs,
causing mortality. These results may have important
implications for the development of 64 TRPs-based
tick vaccines for the control of multi-tick infestations
and the transmission of tick-borne pathogens.
(B) Transgenic animals resistant to ticks
Novel approaches to modify disease resistance or sus-
ceptibility in livestock are justified by economic and
animal welfare concerns. Successful production of
transgenic livestock has been reported for pigs, sheep,
rabbits and cattle. Current research on the improve-
ment of disease resistance by gene transfer focuses on
three main strategies, such as: (a) somatic gene trans-
fer—nucleic acid vaccines; (b) deletive germ-line
gene transfer—gene knockout; and (c) additive germ-
line gene transfer. These strategies aim at either the
transient or stable expression of components known
to influence non-specific or specific host defense
mechanisms, or the disruption of genes known to
cause susceptibility to disease. One significant advan-
tage of transgenesis is in rapid genetic improvement
of traits of interest as the selection for an animal for
a particular trait involves many years.
Different cattle breeds that evolved independently
may have accumulated different resistance genes.
Identification of a range of resistance genes would
considerably hasten the process of production total-
ly resistant animals. These range of major anti-tick
genes are also potential candidate genes for use in the
development of transgenic cattle. The anti-tick gene
can be introduced into the cattle through somatic gene
transfer (DNA vaccine) or additive germ-line trans-
fer. It is impractical to select for or to introgress poly-
genic resistance into lowly resistance breeds. Trans-
genesis is the only option to improve the tick resis-
tance of such breeds. Before experimentation on the
production of transgenic cattle for tick resistance, the
identification and complete characterisation of the
tick resistant genes of the tropical cattle breeds is im-
perative.
(C) Newer generation acaricides
In the current system of livestock production in de-
veloping countries, the tick control can not be imag-
ined without the use of acaricide despite the increas-
ing resistant tick population. Newer generation aca-
ricides targeting previously not explored metabolic
pathways or bio-molecules synthesis pathway should
be generated and these acaricide should be kept in
reserve to meet out any emergency situations expect-
ed to arrive by the multi-acaricide resistant tick pop-
ulation in future. Newer methodologies like combi-
natorial chemistry and computational biology along
with high throughput screening against a target would
yield newer generation acaricides. Monitoring and
early detection of acaricide resistance is one of the
essential components for successful integrated pest
management (IPM). Such acaricide resistance screen-
ing tests should be available for all the acaricides
which are being used in the field. Early detection of
the resistance, subsequent withdrawal and replace-
ment with another acaricide would sustain the suscep-
tible tick population in the field.
(D) Herbal acaricides
The ethno-veterinary and medical knowledge offers
a range of herbs to be evaluated for their insecticidal
and acaricidal properties. The ingredients of plants
and herbs are known to possess insecticidal, growth
inhibiting, anti-molting and repellent activities. A
number of reports are available on the effect of dif-
ferent extracts of plant material on tick species39–45.86 J  VECT  BORNE  DIS  44, JUNE 2007
In our laboratory, the alcoholic extracts of sitaphal
(Annona squamosa) and neem (Azadirachta indica)
are being evaluated for their acaricidal property
against different life stages of H. a. anatolicum and
B. microplus and the initial results are highly encour-
aging.  Final characterisation of the key active com-
ponents of the tested extracts have the great scope for
commercialisation and have potential to be a part of
IPM for sustainable effect.
Conclusion
The effect of TTBDs will continue to exact a huge
economic loss on livestock industries worldwide .
Control of these pests rests on continuous use of ac-
aricides on and off the hosts. Long-term use of these
chemicals is leading to the development of resistance,
issues around the residues in livestock products and
in environment and their undesirable effects.
Recent advances in vector biology open new possi-
bilities in target identification and vaccine develop-
ment. The efforts to characterise the genomes of I.
scapularis and B. microplus46,47 will impact on the
discovery of new tick-protective antigens. The use of
the information in conjugation with functional anal-
ysis using bioinformatics, RNAi, mutagenesis, im-
munomapping, transcriptomics, proteomics, ELI and
other technologies will allow for a rapid, systematic
approach to tick vaccine discovery. Vaccination tri-
als can be designed to evaluate the effect of selected
tick antigens in combination with other tick protec-
tive and pathogen-specific antigens, for improving
the level of tick infestations and reducing transmis-
sion of tick-borne pathogens. The future of research
on development of tick vaccines is exciting because
of new and emerging technologies for gene discov-
ery that facilitate the efficient and rapid identification
of candidate vaccine antigens. These new tick vac-
cines will probably play a key role in future integrat-
ed tick control strategies in cattle and in companion
animals. Tick genomics and proteomics are likely to
evolve into projects addressing the sequencing, anno-
tation and functional analysis of entire tick genomes,
providing invaluable information for the develop-
ment of tick vaccines.
Reduction in the transmission of TBDs by vaccina-
tion against tick vectors is documented. The lack of
effective vaccines against the TBDs of man and an-
imals force us to look into strategic control of tick
vectors in an integrated format for the effective con-
trol of TBDs. Globally two tick research groups14,15
are trying to develop an effective vaccine against tick
vectors of animals to reduce the transmission of TBE
virus to man.  In the same line, immunological con-
trol of H. spinigera, tick vector of KFD on cattle, and
other wild reservoirs of KFD virus in the endemic
area is expected to reduce the transmission of KFD
to man. An oral vaccination strategy using baits could
be an option to immunise the monkeys, the amplifi-
er host of KFD virus. It is unfortunate that India that
suffered the endemic of KFD had no programme or
research group to explore the possibility of develop-
ing a vaccine against H. spinigera, tick vector of
KFD. There is an urgent need to develop a multidis-
ciplinary programme for the control of KFD and other
tick transmitted human diseases utilising the princi-
ple of IPM.
For the future, we must conserve what we have and
use it in combination with all the principles of IPM
like strategic and focused treatments of animals, dis-
ease management, modification of the vectorial ca-
pacity and resistant breeds. Governments and differ-
ent nodal agencies associated with livestock improve-
ment particularly in developing countries should
develop effective policies that ensure sustainable
services and market development.
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